81 related articles for article (PubMed ID: 10441393)
1. Benzodiazepine compounds as inhibitors of the src protein tyrosine kinase: screening of a combinatorial library of 1,4-benzodiazepines.
Ramdas L; Bunnin BA; Plunkett MJ; Sun G; Ellman J; Gallick G; Budde RJ
Arch Biochem Biophys; 1999 Aug; 368(2):394-400. PubMed ID: 10441393
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
3. Structure-based virtual screening of Src kinase inhibitors.
Lee K; Kim J; Jeong KW; Lee KW; Lee Y; Song JY; Kim MS; Lee GS; Kim Y
Bioorg Med Chem; 2009 Apr; 17(8):3152-61. PubMed ID: 19321350
[TBL] [Abstract][Full Text] [Related]
4. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell.
Rapecki S; Allen R
J Pharmacol Exp Ther; 2002 Dec; 303(3):1325-33. PubMed ID: 12438558
[TBL] [Abstract][Full Text] [Related]
6. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.
Ghosh S; Zheng Y; Jun X; Mahajan S; Mao C; Sudbeck EA; Uckun FM
Clin Cancer Res; 1999 Dec; 5(12):4264-72. PubMed ID: 10632369
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.
Hamby JM; Connolly CJ; Schroeder MC; Winters RT; Showalter HD; Panek RL; Major TC; Olsewski B; Ryan MJ; Dahring T; Lu GH; Keiser J; Amar A; Shen C; Kraker AJ; Slintak V; Nelson JM; Fry DW; Bradford L; Hallak H; Doherty AM
J Med Chem; 1997 Jul; 40(15):2296-303. PubMed ID: 9240345
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.
Banes A; Florian JA; Watts SW
J Pharmacol Exp Ther; 1999 Dec; 291(3):1179-87. PubMed ID: 10565840
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase.
Huang H; Ma J; Shi J; Meng L; Jiang H; Ding J; Liu H
Bioorg Med Chem; 2010 Jul; 18(13):4615-24. PubMed ID: 20570525
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of hydroxamate derivatives as metal-mediated inhibitors of a protein tyrosine kinase.
Gu X; Wang Y; Kumar A; Ye G; Parang K; Sun G
J Med Chem; 2006 Dec; 49(25):7532-9. PubMed ID: 17149882
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest.
Moasser MM; Srethapakdi M; Sachar KS; Kraker AJ; Rosen N
Cancer Res; 1999 Dec; 59(24):6145-52. PubMed ID: 10626805
[TBL] [Abstract][Full Text] [Related]
13. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.
Golas JM; Arndt K; Etienne C; Lucas J; Nardin D; Gibbons J; Frost P; Ye F; Boschelli DH; Boschelli F
Cancer Res; 2003 Jan; 63(2):375-81. PubMed ID: 12543790
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening.
Lin LG; Xie H; Li HL; Tong LJ; Tang CP; Ke CQ; Liu QF; Lin LP; Geng MY; Jiang H; Zhao WM; Ding J; Ye Y
J Med Chem; 2008 Aug; 51(15):4419-29. PubMed ID: 18610999
[TBL] [Abstract][Full Text] [Related]
15. Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes.
Kansra S; Stoll SW; Johnson JL; Elder JT
Mol Pharmacol; 2005 Apr; 67(4):1145-57. PubMed ID: 15615697
[TBL] [Abstract][Full Text] [Related]
16. Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.
Shakespeare WC; Metcalf CA; Wang Y; Sundaramoorthi R; Keenan T; Weigele M; Bohacek RS; Dalgarno DC; Sawyer TK
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):729-41. PubMed ID: 14579523
[TBL] [Abstract][Full Text] [Related]
17. Rational design of multitargeted tyrosine kinase inhibitors: a novel approach.
Barchéchath S; Williams C; Saade K; Lauwagie S; Jean-Claude B
Chem Biol Drug Des; 2009 Apr; 73(4):380-7. PubMed ID: 19291100
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines.
Ma XH; Wang R; Tan CY; Jiang YY; Lu T; Rao HB; Li XY; Go ML; Low BC; Chen YZ
Mol Pharm; 2010 Oct; 7(5):1545-60. PubMed ID: 20712327
[TBL] [Abstract][Full Text] [Related]
19. The influence of SRC-family tyrosine kinases on Na,K-ATPase activity in lens epithelium.
Bozulic LD; Dean WL; Delamere NA
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):618-22. PubMed ID: 15671290
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors.
Blencke S; Zech B; Engkvist O; Greff Z; Orfi L; Horváth Z; Kéri G; Ullrich A; Daub H
Chem Biol; 2004 May; 11(5):691-701. PubMed ID: 15157880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
